CLINICAL_TRIALS
trial_result
· 2016-08-17
Clinical Trial Update: A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin [Phase 2]
Summary
A Phase 2 study evaluating salvage therapy with a combination of docetaxel and epirubicin for metastatic advanced gastric cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yonsei University | Conditions: Metastatic Advanced Gastric Cancer | Phase 2 | Status: COMPLETED